Anthem Biosciences Ltd.
957.80+24.3 (+2.60%)
8 Sep, 3:30 PM
Stock News
Anthem Biosciences Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Moneycontrol
Jefferies sees Big Pharma RFPs strengthening order cycle for Indian CRDMOs
Anthem Biosciences has more than 80% visibility on FY27 revenue but had a tough June quarter as key product shipments are scheduled only from the second quarter of FY27, with Jefferies retaining a Buy rating.
4th Sep '26 8:46 am
Read full article on moneycontrol.com